Critical Analysis of the Efficacy and Limitations of GLP-1 Pharmaceuticals in Obesity Management: A Comprehensive Literature Review
Open Access
- 26 January 2024
- journal article
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 55, 87-103
Abstract
Introduction and purpose Obesity, a pervasive global pandemic intricately linked to various comorbidities, necessitates a comprehensive and nuanced approach. This article delves into the intricate realm of obesity guidelines, underscoring the significance of lifestyle modifications, preventive measures for childhood obesity, population-based strategies, clinical management protocols, and vigilant monitoring. GLP-1 drugs, originally designed for type 2 diabetes management, exhibit multifaceted effects beyond glycemic control. They influence appetite regulation, gastric emptying dynamics, and potentially contribute to cardiovascular health improvements. However, the commendable effects come with a caveat - potential side effects necessitating careful consideration in clinical decision-making. Despite gaining popularity through celebrity endorsements, this article firmly underscores the need to view GLP-1 pharmacotherapy as a recommended intervention rather than a miraculous solution. A brief description of the state of knowledge Integral to the obesity discourse is the imperative to address weight stigma, demanding evidence-based approaches in both clinical and public health domains. The narrative extends into the future landscape of obesity pharmacotherapy, contemplating the potential role of probiotics. Emphasizing the necessity for long-term studies and randomized trials, it positions probiotics as a low-risk alternative with significant potential in mitigating obesity while simultaneously addressing concerns related to antibiotic resistance. Summary The pursuit of a balanced and effective approach to obesity management necessitates a nuanced understanding of medical interventions, consideration of societal perceptions, and exploration of innovative possibilities within the evolving landscape of healthcare.Keywords
This publication has 21 references indexed in Scilit:
- Physical activity behaviours in adolescence: current evidence and opportunities for interventionThe Lancet, 2021
- Joint international consensus statement for ending stigma of obesityNature Medicine, 2020
- Effects of GLP-1 and Its Analogs on Gastric Physiology in Diabetes Mellitus and Obesity2020
- Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trialThe Lancet, 2018
- Obesity StatisticsPrimary Care: Clinics in Office Practice, 2016
- Position of the Academy of Nutrition and Dietetics: Interventions for the Treatment of Overweight and Obesity in AdultsJournal of the Academy of Nutrition and Dietetics, 2016
- Overweight and Obesity: Prevalence, Consequences, and Causes of a Growing Public Health ProblemCurrent Obesity Reports, 2015
- Quantitative Gastrointestinal and Psychological Traits Associated With Obesity and Response to Weight-Loss TherapyGastroenterology, 2015
- Liraglutide: A Review of Its Use in Adult Patients with Type 2 Diabetes MellitusDrugs, 2014
- Glucagon-like peptide-1 receptor agonists and pancreatitis: A meta-analysis of randomized clinical trialsDiabetes Research and Clinical Practice, 2014